Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
14.10
+1.24 (9.64%)
At close: May 9, 2025, 4:00 PM
14.06
-0.04 (-0.28%)
After-hours: May 9, 2025, 7:40 PM EDT
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $850.99 million as of May 9, 2025. Its market cap has decreased by -28.64% in one year.
Market Cap
850.99M
Enterprise Value
286.17M
1-Year Change
-28.64%
Ranking
Category
Stock Price
$14.10
Market Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $850.99M, an increase of 661.85%. That is a compound annual growth rate of 25.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 851.00M | -28.92% |
| Dec 31, 2024 | 1.20B | 1,274.63% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 674.60B |
| Johnson & Johnson | 374.53B |
| UnitedHealth Group | 349.75B |
| AbbVie | 328.29B |
| Novo Nordisk | 287.72B |
| Abbott Laboratories | 233.14B |
| Novartis AG | 215.89B |
| AstraZeneca | 208.98B |